Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab in Peripheral Arterial Disease
NCT04306081Phase 4Unknown
- Start
- Dec 2017
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of evolocumab in Peripheral Arterial Disease (PAD). Status: unknown.
02
Drugs
evolocumab
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT04306081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04306081.